ALS candidates from Biohaven, Prilenia, Clene and UCB have all failed to halt disease progression versus placebo in the US-wide platform trial.

NEW YORK, NY / ACCESS Newswire / February 18, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Voyager ...

The Muscular Dystrophy Association (MDA) today launched the nation’s largest St. Patrick’s Day fundraising campaign, MDA Shamrocks, as part of its celebration of 75 years of progress and impact in ...

Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease characterized by the progressive degeneration ...

Scientists have developed a lipid nanoparticle system capable of delivering messenger RNA (mRNA) to the brain via intravenous injection, a challenge that has long been limited by the protective nature ...

Innovative lipid nanoparticles enable mRNA delivery to the brain, offering new avenues for treating neurological disorders by crossing the blood-brain barrier.

In a statement, the ALS Association opposed any planned National Institutes of Health (NIH) funding cuts, saying it could ...

Deep within the Apple operating system are capabilities that allow users to summon apps, send emails and texts, play music ...

A New Milford mom said she believes Dr. Sabooh Mubbashar, who is the medical director of the HFSC Autism Inpatient Unit, is ...

Scientists at the Icahn School of Medicine at Mount Sinai have developed a lipid nanoparticle system capable of delivering ...

Having access to neurofilament light chain and the ALS Functional Rating Scale-Revised test results is informational to ALS ...